1 Health Care Vendor Relations A new UCOP Presidential Policy Lee Giddings, M.D. Chief Compliance Officer UCSD Health Sciences May 2008 Revised: 05/05/2008.

Slides:



Advertisements
Similar presentations
Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
Advertisements

CME 101 The Application Process Sponsored by the Office of Continuing Medical Education.
Continuing Professional Development Conflict of Interest This presentation has been developed by the COI Working Group to assist in the implementation.
1 UMass Dartmouth Conflicts of Interest Policies UMass Dartmouth Liz Rodriguez February 17, 2011.

Types of Cost Sharing Mandatory: When the sponsor stipulates that cost sharing or matching funds are required as a condition of receiving an award. Specifically.
Grant Guidance Changes
HIPAA Privacy Rule Training
Commercial support is defined as financial or in- kind contributions given by a commercial interest, which is used to pay all or part of the costs of a.
1 OSHA FEDERAL OCCUPATIONAL SAFETY AND HEALTH ACT (OSHA) OF 1970 George Mason University College of Nursing and Health Science Regulatory Requirements.
Pharmaceutical Compliance Congress: “State of the States” October 27, 2008 Janice G. Cunningham Jeffrey L. Handwerker.
1 Physician-Industry Transparency: The U.S. Physician Payment Sunshine Act.
Sales & Marketing Compliance Training
1 UCDHS Vendor Relations Policy Development & Implementation Teresa Porter, CHC - Chief Compliance Officer David Levine, JD - Legal Counsel Allan Siefkin,
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
Version 6.0 Approved by HIPAA Implementation Team April 14, HIPAA Learning Module The following is an educational Powerpoint presentation on the.
UNIFORM GUIDANCE OVERVIEW. OMB Circulars Before and After A-21 Cost principles for Educational Institutions A-21 Cost principles for Educational Institutions.
(rev 3/09) Stewardship, Accountability and Regulatory Compliance Jim Corkill Sandra Featherson Office of the Controller.
Minnesota Law and Health Information Exchange Oversight Activities James I. Golden, PhD State Government Health IT Coordinator Director, Health Policy.
Promoting Objectivity in Research by Managing, Reducing, or Eliminating Conflicts of Interest UT HOP UT HOP The University of Texas at Austin.
Five Activities Contracting Officers and Government Contractors Should Avoid Presented by: James F. Moseley, Jr. of Moseley, Prichard, Parrish, Knight,
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress Compliance Best Practices in a Post Orthopedic Environment David Matyas.
# Operating Under the New Compliance Environment: Considerations for the Pharmaceutical Industry The Impact of the new Medicare Prescription Drug benefit.
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
VCU School of Medicine Policy on Industry Relations Effective July 1, 2009.
Copyright © 2005 Thomson Delmar Learning. ALL RIGHTS RESERVED.1 This product was funded by a grant awarded under the President’s Community-Based Job Training.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
© 2008 Foley Hoag LLP. All Rights Reserved. 1 The New Massachusetts Pharmaceutical & Medical Device Marketing Regulations How to Address and Overcome Likely.
New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014.
State Ethics & Lobbying Laws for Pharmaceutical and Medical Device Companies John T. Bentivoglio (202) Steve Benz
How to Develop Internal Monitoring Programs SEVENTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM Stephen F. Mohr Global.
U.S. Department of Education Privacy Initiatives Kathleen M. Styles Chief Privacy Officer U.S. Department of Education April 18, 2011.
Copyright ©2011 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. Health Information Technology and Management Richard.
Computerized Networking of HIV Providers Workshop Data Security, Privacy and HIPAA: Focus on Privacy Joy L. Pritts, J.D. Assistant Research Professor Health.
Pitfalls and Lessons Learned: Advanced Implementation Strategies for a Compliant Grant Process National CME Audioconference December 9, 2008.
CONFLICTS OF INTEREST PRESENTED BY THE UMMC OFFICE OF INTEGRITY AND COMPLIANCE.
Office of the Vice Chancellor for Research 1 Update on PHS New Rule on Financial Conflicts of Interest (FCOI) Presentation to Business Managers January.
Family Educational Rights and Privacy Act (FERPA) UNION COLLEGE.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
A Focus on CME and Grants Nancy Coddington, PhD Senior Director, Compliance Operations AstraZeneca Pharmaceuticals LP And Terry Hisey Deputy Managing Principal.
University of Pittsburgh Presentation to Schools of Pharmacy and Nursing: Consulting Requirements within the Industry Relationship Policy Presented by.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
February 16, The Gift Ban Revolving Door Political Activities Ex Parte Communications.
Fight On Training on NIH Conflict of Interest Rule and Introduction to diSClose Dan Shapiro Director, Research Compliance Ben Bell Manager, Research Compliance.
+ Role of Industry in Clinical Care, Research, and Education.
Managing Conflicts of Interest at the IRB and Institutional Level: INSTITUTIONAL CONFLICTS OF INTEREST Claudia R. Adkison, J.D., Ph.D. Executive Associate.
New Federal Policy on Financial Conflicts of Interest Matt Richter, MA, JD anticipated 2012 COI Program Specialist Office of Research Policy
Partners Conflict of Interest Policy and Reporting October 11, 2012.
An Educational Session on HSC OP 10.27, Health Care Vendor Interactions April 20, 2009.
1 Continuing Medical Education and Industry Sponsorship The Pharma, Biotech and Device Colloquium Princeton, NJ June 7, 2005 Julie K. Taitsman, M.D., J.D.
1 Harvard University Cambridge, MA March 29, 2007 Medical Device Congress AdvaMed’s Efforts to Promote Compliance Christopher L. White, Esq. Executive.
SDCCD–CAREER TECHNICAL EDUCATION ACT (CTEA) Budget and Perkins Requirements.
Oregon Government Ethics Commission Oregon Government Ethics Commission An Overview of Oregon Government Ethics Law An Overview of Oregon Government Ethics.
Shelly Rose Ziegler. Overview Gifts from Industry Industry Site Access Academic Activities Questions  Growing external perception that industry has influence.
Oregon Government Ethics Commission Oregon Government Ethics Commission An Overview of Oregon Government Ethics Law An Overview of Oregon Government Ethics.
California’s New Compliance Law Kelly N. Reeves
Compliance Issues in Dealing With Drug and Device Manufacturers Presentation to The Sixth Annual National Congress On Health Care Compliance Paul E. Kalb,
California Department of Public Health / 1 CALIFORNIA DEPARTMENT OF PUBLIC HEALTH Standards and Guidelines for Healthcare Surge during Emergencies How.
Using This Presentation UE encourages you to share content from Risk Research Bulletin with others on your campus who you believe will benefit from it.
1 Stewardship, Accountability and Regulatory Compliance October 22, 2015 Stewardship, Accountability and Regulatory Compliance Jim Corkill | Controller.
Compensation Plan & Incentive Pay Making Sense of X,Y, and Z New Faculty Orientation UCSF Radiology and Biomedical Imaging Session 1: September 17, 2014.
Disclosure of Financial Interest Policy. Medical Staff Policy Approved by the MEC’s Aimed at protecting the integrity of the LMHS Medical Staffs Requires.
HIPAA Privacy Rule Training
Brustein & Manasevit, PLLC
OVERVIEW UNIVERSITY AT ALBANY.
University of Pittsburgh
Disability Services Agencies Briefing On HIPAA
2017 College of Medicine Compliance & Privacy R
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Presentation transcript:

1 Health Care Vendor Relations A new UCOP Presidential Policy Lee Giddings, M.D. Chief Compliance Officer UCSD Health Sciences May 2008 Revised: 05/05/2008

2 Vendor Relations – Outline Introduction Background Key Elements Training Monitoring High Risk Areas Key Elements: I. Access II. Gifts III. Promotional Activity IV. Preceptorships V. Publicity of Support VI. Anti-Kickback Law

3 Vendor Relations – Introduction “Policy on Health Care Vendor Relations” (PP031208) Approved: Officially signed by President Dynes – Mar. 12, 2008 Implementation: July 1, 2008 Endorsed by: UC Academic Senate UC Chancellors UC Health Science Vice Chancellors Work Group: Representation from all Health Science campuses Chaired by Rory Jaffe, M.D., Executive Director, Medical Services

4 Vendor Relations – Introduction Definition: Health Care Vendor. A company or its representative or the agent of a company that either produces or markets drugs, devices, nutritional products, or other medical products or services. Scope: All UCSD Health Science workforce members, both on and off campus (unless specifically noted)

5 Vendor Relations – Background California Political Reform Act (CPRA) of 2001 Attempts to remove bias from product decisions Financial COI focus; does not eliminate all conflicts Purpose of UCOP Policy To manage the perceived potential for industry unduly influencing health care decisions Not a Conflict of Interest (COI) Policy Supplements existing UC policies* Initiative Supported by: AMC National Trends Evidence based literature (Brennan, JAMA 2006; 295 (4): ) Increased regulatory scrutiny * Business & Finance Bulletin, G-39; COI Policy; Clinic Sample Policy, MCP 321.7; Regulations for Sales Representatives, MCP 550.1

6 Vendor Relations – Key Elements I.Vendor Access Vendors must register & wear ID badge (VendorClear); (addresses patient confidentiality provisions) Vendors must have scheduled appointments Appointments in non-clinical areas only Can not access patient information without written consent Anticipated FAQs Vendor may enter patient care areas if:  Pre-registered and requested by a UC representative  Providing a specific health care support service  Servicing equipment  Or as a patient or member of the general public

7 Vendor Relations – Key Elements II.Vendor Gifts Prohibits gifts provided directly to individuals Definition of Gift: Anything of value (including compensation) without providing a service of equivalent or greater value in exchange. Examples of gifts: Free food, pens, notepads, supplies, books Free samples Free equipment Travel and lodging Paid attendance or registration fees for conferences

8 Vendor Relations – Key Elements II.Vendor Gifts - Anticipated FAQs: The following are not considered a gift: Honoraria at Fair Market Value for legitimate service Food, travel, admission fee while providing a service Prizes or competitive awards Items provided at a discount or free as part of a University contract or a research project Refreshments, non-cash nominal benefits and materials provided by the organizers of a professional meeting and available to all attendees.  Example: CME Conference tote bags

9 Vendor Relations – Key Elements II.Vendor Gifts Prohibits samples in all UCSDHS sites Prohibits samples for personal use Alternatives: Vendor may donate “samples” for UC’s free clinics  Product must be on the UCSDMC formulary  Product storage / distribution must adhere to regulatory requirements Vendor may donate “product” for evaluation or education purposes. The amount is restricted to the minimum necessary for the intended use. [Refer to MCP 405.1]

10 Vendor Relations – Key Elements II.Vendor Gifts Alternatives: Patient Assistance Programs available through the UCSDMC Pharmacy. Vendor may donate “funds” to support the mission of the University (education, research, patient care) Examples of Permitted Uses of Vendor Funds: -Educational meetings (non-CME) -Departmental Activities -Purchase of food -Purchase of travel -Fundraising activities -Grants * -Fellowships Vendor can NOT: -Select speakers -Control content -Select recipients -Attend meetings * Research grants from industry require 700-U form submission & IRB approval.

11 Vendor Relations – Key Elements II.Vendor Gifts “Donations” must comply with standards and procedures of: ACCME (or equivalent) UCSD Office of Continuing Medical Education (OCME) (whether or not educational credit is offered) UCSD Office of Gift Administration (OGA) UCSD Office of Contracts & Grants Administration (OCGA) UCSD Conflict of Interest Office (COI) California Political Reform Act

12 Vendor Relations – Key Elements III.Vendor Promotional Material & Activity Prohibits branded items with company logos in all UCSDHS sites Prohibits meals, snacks, beverages directly provided by a vendor in all UCSDHS sites Anticipated FAQs: Patient education materials which are branded and needed for unique patient education purposes may be used at the discretion of individual providers, but should be free of all product promotion and bias.

13 Vendor Relations – Key Elements IV.Vendor Preceptorships An educational program for vendor representative(s) Requires a written service agreement (Dean’s Office) & oversight by UCSD OCME Requires compliance with HIPAA Privacy Rules & patient consent in clinical areas Preceptorship must not provide a vendor with sales and marketing opportunities Anticipated FAQs: A vendor has the same access to official educational offerings of the University as other members of the general public.

14 Vendor Relations – Key Elements V.Publicity of Industry Support California Public Records Act  Provides that information about industry support of the University is a public record APM-025  Requires faculty to report annually time spent in outside professional activity (OPA), which becomes a public record VI.Anti-Kickback Law The Federal Anti-Kickback Statute prohibits the solicitation or receipt of anything of value in return for patient referrals or to induce such referrals which could potentially be reimbursed by a government payer.

15 Vendor Relations – Training Vendors Registration process with Medical Center Purchasing Department (VendorClear) Workforce Members Train-the-trainer Faculty / Staff meetings Web postings Educational bulletins, memos, FAQs Learning management system (LMS) modules

16 Vendor Relations – Monitoring Vendors Enforce ID badge requirement Exclude from UCSDHS sites for repeated violations Send written report of violations / actions to company Physicians Collaborate to build awareness / change culture Department Chair / physician leaders as champions & role models Managers Discard branded items and literature Notify Pharmacy to retrieve samples for disposal Prohibit vendor provided food; notify Purchasing of violations Committees Guidance and oversight by established UCSDHS Committees Enforcement Corrective actions in accordance with UCSD & HR policies 15

17 Vendor Relations – High Risk Areas Activities to avoid… Sham honoraria or sham consulting agreements Compensation should be an equivalent value for legitimate services Luxurious off-site meetings & meals Entertainment unrelated to educational goals Free trips and tickets Speakers bureau & ghostwriting Vendor control or influence of the content of a presentation is prohibited Off-Label promotion (marketing)

18 Vendor Relations – Safeguards Managing HC Industry Vendor Relationships Disclose – financial relationships to Purchasing, CME sponsor, audiences (learners) & patients Recuse – from product purchase decisions for 12 months Seek – advice from the UCSD Conflict of Interest Office and your personal attorney Ask – assess your comfort level with potential public exposure or scrutiny

19 Questions? Lee Giddings, M.D. Larry Friedman, M.D. Charles Daniels, Ph.D., R.Ph. Kathleen Naughton UCOP policy site: “Policy on Health Care Vendor Relations” Policy Issuance Letter – President Dynes (03/12/2008)